Industry Outlook & Insights
With the shift to outcomes-based models and advances in digital technologies, many executives are taking a fresh look at their investment and innovation strategies.
Deloitte’s R&D Survey (https://www2.deloitte.com/insights/us/en/industry/life-sciences/medtech-research-and-development-innovation.html) found that to build differentiated products, many companies are shifting investments away from core products and line extensions toward transformational innovation: innovation that creates and delivers customer value through novel products, solutions, and business models that address unmet market needs. Companies expect to increase the proportion of R&D budgets they spend on transformational innovation by 5 percentage points in the next two years.
Hear from CEOs who are leading the charge in transformational innovation. Learn how digital capabilities and the shift to value- based care have fueled their investment and innovation strategies, shifted priorities, and set the stage for the future.